It can inhibit angiogenesis in tumor tissues and block cancer cell proliferation by inhibiting kinase activities, such as those of c-Raf, VEGFR2, VEGFR3, which can affect the function of the skin and blood vessels leading to HFSR (42). Here, FLT4 is linked to neoplasm.